Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma
Saved in:
| Title: | Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma |
|---|---|
| Authors: | Schrecker, Christopher, Schulze, Falko, Trojan, Jörg, Bechstein, Wolf Otto, Zeuzem, Stefan, Koch, Christine |
| Source: | J Cancer Res Clin Oncol |
| Publisher Information: | Springer Science and Business Media LLC, 2024. |
| Publication Year: | 2024 |
| Subject Terms: | Liver Cirrhosis, Cirrhosis, Liver Cirrhosis/diagnosis [MeSH], FIB-4, Liver Neoplasms/diagnosis [MeSH], Research, Humans [MeSH], Carcinoma, Hepatocellular/diagnosis [MeSH], APRI, Retrospective Studies [MeSH], Fibrosis, HCC, 03 medical and health sciences, Carcinoma, Hepatocellular, 0302 clinical medicine, Liver Neoplasms, Humans, Retrospective Studies |
| Description: | Purpose Hepatocellular carcinoma (HCC) arises in individuals with underlying liver disease. Diagnosing the degree of hepatic fibrosis helps to determine the severity of the underlying liver disease and may influence therapeutic decisions in HCC patients. Non-invasive fibrosis scores can be used to estimate the degree of fibrosis in liver disease patients, but most of these scores were developed in patients with viral hepatitis and without HCC. This study explored the ability of the Fibrosis-4 Index (FIB-4), the AST/Platelet Ratio Index (APRI), and the AST/ALT ratio to diagnose or exclude advanced fibrosis (METAVIR F3/4 versus F0-2) in patients with early-intermediate, potentially resectable HCC. Methods We retrospectively reviewed 119 patients who underwent hepatic resection for HCC at a tertiary centre (2007–2019), 75 of whom had advanced fibrosis (prevalence 63%). Histological assessment of the surgical liver specimen was used as a reference standard for the degree of fibrosis. Results Overall diagnostic performance was highest for the FIB-4 Index, with an area under the receiver operating characteristic curve (AUROC) of 0.82, compared with 0.78 for APRI, and 0.56 for the AST/ALT ratio. Using established cut-off values, FIB-4 achieved a 90% positive predictive value at the higher cut-off (3.25) and a 90% negative predictive value at the lower cut-off (1.45). Conclusion The FIB-4 Index could reliably diagnose or exclude advanced fibrosis in patients with early-intermediate HCC, and may thus have a role in guiding therapeutic decisions in these patients. |
| Document Type: | Article Other literature type |
| Language: | English |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-024-05708-3 |
| Access URL: | https://pubmed.ncbi.nlm.nih.gov/38602548 https://repository.publisso.de/resource/frl:6499020 |
| Rights: | CC BY |
| Accession Number: | edsair.doi.dedup.....d67f6e9d405ecb5ffb2bc8c518d8c2e6 |
| Database: | OpenAIRE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://explore.openaire.eu/search/publication?articleId=doi_dedup___%3A%3Ad67f6e9d405ecb5ffb2bc8c518d8c2e6 Name: EDS - OpenAIRE (s4221598) Category: fullText Text: View record at OpenAIRE – Url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pmc&term=1432-1335[TA]+AND+[PG]+AND+2024[PDAT] Name: FREE - PubMed Central (ISSN based link) Category: fullText Text: Full Text Icon: https://imageserver.ebscohost.com/NetImages/iconPdf.gif MouseOverText: Check this PubMed for the article full text. – Url: https://resolver.ebscohost.com/openurl?sid=EBSCO:edsair&genre=article&issn=14321335&ISBN=&volume=150&issue=&date=20240411&spage=&pages=&title=Journal of Cancer Research and Clinical Oncology&atitle=Diagnostic%20performance%20of%20non-invasive%20liver%20fibrosis%20scores%20in%20patients%20with%20early-intermediate%20hepatocellular%20carcinoma&aulast=Schrecker%2C%20Christopher&id=DOI:10.1007/s00432-024-05708-3 Name: Full Text Finder Category: fullText Text: Full Text Finder Icon: https://imageserver.ebscohost.com/branding/images/FTF.gif MouseOverText: Full Text Finder – Url: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=EBSCO&SrcAuth=EBSCO&DestApp=WOS&ServiceName=TransferToWoS&DestLinkType=GeneralSearchSummary&Func=Links&author=Schrecker%20C Name: ISI Category: fullText Text: Nájsť tento článok vo Web of Science Icon: https://imagesrvr.epnet.com/ls/20docs.gif MouseOverText: Nájsť tento článok vo Web of Science |
|---|---|
| Header | DbId: edsair DbLabel: OpenAIRE An: edsair.doi.dedup.....d67f6e9d405ecb5ffb2bc8c518d8c2e6 RelevancyScore: 924 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 924.292297363281 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Schrecker%2C+Christopher%22">Schrecker, Christopher</searchLink><br /><searchLink fieldCode="AR" term="%22Schulze%2C+Falko%22">Schulze, Falko</searchLink><br /><searchLink fieldCode="AR" term="%22Trojan%2C+Jörg%22">Trojan, Jörg</searchLink><br /><searchLink fieldCode="AR" term="%22Bechstein%2C+Wolf+Otto%22">Bechstein, Wolf Otto</searchLink><br /><searchLink fieldCode="AR" term="%22Zeuzem%2C+Stefan%22">Zeuzem, Stefan</searchLink><br /><searchLink fieldCode="AR" term="%22Koch%2C+Christine%22">Koch, Christine</searchLink> – Name: TitleSource Label: Source Group: Src Data: J Cancer Res Clin Oncol – Name: Publisher Label: Publisher Information Group: PubInfo Data: Springer Science and Business Media LLC, 2024. – Name: DatePubCY Label: Publication Year Group: Date Data: 2024 – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Liver+Cirrhosis%22">Liver Cirrhosis</searchLink><br /><searchLink fieldCode="DE" term="%22Cirrhosis%22">Cirrhosis</searchLink><br /><searchLink fieldCode="DE" term="%22Liver+Cirrhosis%2Fdiagnosis+[MeSH]%22">Liver Cirrhosis/diagnosis [MeSH]</searchLink><br /><searchLink fieldCode="DE" term="%22FIB-4%22">FIB-4</searchLink><br /><searchLink fieldCode="DE" term="%22Liver+Neoplasms%2Fdiagnosis+[MeSH]%22">Liver Neoplasms/diagnosis [MeSH]</searchLink><br /><searchLink fieldCode="DE" term="%22Research%22">Research</searchLink><br /><searchLink fieldCode="DE" term="%22Humans+[MeSH]%22">Humans [MeSH]</searchLink><br /><searchLink fieldCode="DE" term="%22Carcinoma%2C+Hepatocellular%2Fdiagnosis+[MeSH]%22">Carcinoma, Hepatocellular/diagnosis [MeSH]</searchLink><br /><searchLink fieldCode="DE" term="%22APRI%22">APRI</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+Studies+[MeSH]%22">Retrospective Studies [MeSH]</searchLink><br /><searchLink fieldCode="DE" term="%22Fibrosis%22">Fibrosis</searchLink><br /><searchLink fieldCode="DE" term="%22HCC%22">HCC</searchLink><br /><searchLink fieldCode="DE" term="%2203+medical+and+health+sciences%22">03 medical and health sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Carcinoma%2C+Hepatocellular%22">Carcinoma, Hepatocellular</searchLink><br /><searchLink fieldCode="DE" term="%220302+clinical+medicine%22">0302 clinical medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Liver+Neoplasms%22">Liver Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+Studies%22">Retrospective Studies</searchLink> – Name: Abstract Label: Description Group: Ab Data: Purpose Hepatocellular carcinoma (HCC) arises in individuals with underlying liver disease. Diagnosing the degree of hepatic fibrosis helps to determine the severity of the underlying liver disease and may influence therapeutic decisions in HCC patients. Non-invasive fibrosis scores can be used to estimate the degree of fibrosis in liver disease patients, but most of these scores were developed in patients with viral hepatitis and without HCC. This study explored the ability of the Fibrosis-4 Index (FIB-4), the AST/Platelet Ratio Index (APRI), and the AST/ALT ratio to diagnose or exclude advanced fibrosis (METAVIR F3/4 versus F0-2) in patients with early-intermediate, potentially resectable HCC. Methods We retrospectively reviewed 119 patients who underwent hepatic resection for HCC at a tertiary centre (2007–2019), 75 of whom had advanced fibrosis (prevalence 63%). Histological assessment of the surgical liver specimen was used as a reference standard for the degree of fibrosis. Results Overall diagnostic performance was highest for the FIB-4 Index, with an area under the receiver operating characteristic curve (AUROC) of 0.82, compared with 0.78 for APRI, and 0.56 for the AST/ALT ratio. Using established cut-off values, FIB-4 achieved a 90% positive predictive value at the higher cut-off (3.25) and a 90% negative predictive value at the lower cut-off (1.45). Conclusion The FIB-4 Index could reliably diagnose or exclude advanced fibrosis in patients with early-intermediate HCC, and may thus have a role in guiding therapeutic decisions in these patients. – Name: TypeDocument Label: Document Type Group: TypDoc Data: Article<br />Other literature type – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 1432-1335 – Name: DOI Label: DOI Group: ID Data: 10.1007/s00432-024-05708-3 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://pubmed.ncbi.nlm.nih.gov/38602548" linkWindow="_blank">https://pubmed.ncbi.nlm.nih.gov/38602548</link><br /><link linkTarget="URL" linkTerm="https://repository.publisso.de/resource/frl:6499020" linkWindow="_blank">https://repository.publisso.de/resource/frl:6499020</link> – Name: Copyright Label: Rights Group: Cpyrght Data: CC BY – Name: AN Label: Accession Number Group: ID Data: edsair.doi.dedup.....d67f6e9d405ecb5ffb2bc8c518d8c2e6 |
| PLink | https://erproxy.cvtisr.sk/sfx/access?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsair&AN=edsair.doi.dedup.....d67f6e9d405ecb5ffb2bc8c518d8c2e6 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00432-024-05708-3 Languages: – Text: English Subjects: – SubjectFull: Liver Cirrhosis Type: general – SubjectFull: Cirrhosis Type: general – SubjectFull: Liver Cirrhosis/diagnosis [MeSH] Type: general – SubjectFull: FIB-4 Type: general – SubjectFull: Liver Neoplasms/diagnosis [MeSH] Type: general – SubjectFull: Research Type: general – SubjectFull: Humans [MeSH] Type: general – SubjectFull: Carcinoma, Hepatocellular/diagnosis [MeSH] Type: general – SubjectFull: APRI Type: general – SubjectFull: Retrospective Studies [MeSH] Type: general – SubjectFull: Fibrosis Type: general – SubjectFull: HCC Type: general – SubjectFull: 03 medical and health sciences Type: general – SubjectFull: Carcinoma, Hepatocellular Type: general – SubjectFull: 0302 clinical medicine Type: general – SubjectFull: Liver Neoplasms Type: general – SubjectFull: Humans Type: general – SubjectFull: Retrospective Studies Type: general Titles: – TitleFull: Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schrecker, Christopher – PersonEntity: Name: NameFull: Schulze, Falko – PersonEntity: Name: NameFull: Trojan, Jörg – PersonEntity: Name: NameFull: Bechstein, Wolf Otto – PersonEntity: Name: NameFull: Zeuzem, Stefan – PersonEntity: Name: NameFull: Koch, Christine IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 04 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 14321335 – Type: issn-locals Value: edsair – Type: issn-locals Value: edsairFT Numbering: – Type: volume Value: 150 Titles: – TitleFull: Journal of Cancer Research and Clinical Oncology Type: main |
| ResultId | 1 |
Full Text Finder
Nájsť tento článok vo Web of Science